Cognition Life Science Retains World Expert in Snoring and Sleep Apnea Surgery
Dr. Eric J. Kezirian, MD, MPH to serve as Scientific Advisor
TAMPA, Fla., March 8, 2016 /PRNewswire/ -- Cognition Life Science, Inc. (CLS), announced today that it has selected Dr. Eric J. Kezirian, MD, MPH to serve as a Scientific Advisor.
Photo - http://photos.prnewswire.com/prnh/20160307/341169
Photo - http://photos.prnewswire.com/prnh/20160307/341170
Eric J. Kezirian, MD, MPH is the only surgeon in Southern California truly specializing in the surgical evaluation and treatment of adults with snoring and obstructive sleep apnea. With offices in Los Angeles and Beverly Hills, he offers a full spectrum of treatment options, from minimally-invasive approaches like Inspire Upper Airway Stimulation and the Pillar Procedure to surgeries performed in the operating room. He has developed videos posted on YouTube to share his unique experience and perspective. Dr. Kezirian is committed to providing outstanding, comprehensive, and state-of-the-art patient care while advancing the field of snoring and sleep apnea surgery through innovation and research. He is a Professor in the Department of Otolaryngology - Head & Neck Surgery at the Keck School of Medicine of the University of Southern California and President of the International Surgical Sleep Society, the world's preeminent organization dedicated to improving the surgical treatment of snoring and sleep apnea.
Raj Pamnani, Chairman of Cognition Life Science, said that "Dr. Kezirian will be reviewing the data for Cognizol and CLS-55 and provide his expert opinion on the proposed therapeutic for Sleep Apnea."
Dr.Kezirian said he is looking forward to reviewing the early data and would be happy to provide scientific advisory consulting services related to the development, production and introduction of the Company's products.
About Cognition Life Science, Inc. – Cognition Life Science, Inc. is a privately held new pharmaceutical company which was formed to explore, acquire and develop proprietary formulations to treat neurodegenerative diseases, sleep disorder, mental acuity and pain management. The company establishes relationships with researchers and accredited laboratories/institutions and explores new ways to deliver existing generic compounds as well as combining natural ingredients which have been shown to be safe and effective. Certain formulations include THC.
For more information, contact:
Cognition Life Science
1302 19th Street, suite 200. Tampa, Florida 33605
Email
813 - 563 0544
Rene de Wit, on behalf of the board.
SOURCE Cognition Life Science Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article